Klinic boasts a team of experienced, board-certified providers in Beaufort, South Carolina, dedicated to guiding you through your semaglutide weight loss journey
KFF research found that 54% of adults who have taken GLP-1 drugs reported difficulty affording the therapy, with 22% stating it was very difficult. Geographic disparities: Patients in rural or underserved areas tend to face significant disparities in accessing GLP-1 therapies
Sun damage, smoking, and hydration also play a role
The system alerts This drug requires prior authorization for this patients insurance
Only a small fraction of people who qualify for GLP-1 medications receive them
It is not approved by the FDA, Health Canada, or any other regulatory authority